One of the most common questions I hear from people considering TMS is whether they need to stop their antidepressants first. It makes sense to ask, because most people starting TMS have already spent years trying different medications, and the idea of giving those up before a new treatment feels unsettling. The short answer is that, in most cases, you do not have to stop your antidepressants to begin TMS and antidepressants can often work alongside each other throughout the full course of treatment. That said, the picture is not exactly the same for every medication or every person, and some combinations do require a more careful review before we move forward. Understanding exactly how these two approaches interact gives you a much clearer foundation for making a decision with your treatment team.
Most people who come to us for TMS are already on at least one psychiatric medication. That is not unusual at all, and in fact it reflects how TMS was designed to be used. The FDA cleared TMS for major depressive disorder in patients who have not responded adequately to antidepressant treatment, which means the average TMS candidate has a medication history, not a blank slate. Research consistently shows that continuing TMS with medication does not reduce how well the therapy works, and for many patients the combination produces better outcomes than either approach alone. The brain stimulation targets the prefrontal cortex directly, while the antidepressant continues to support neurotransmitter activity, and these two mechanisms do not cancel each other out.
What I want people to understand is that TMS is not a replacement for medication in most cases, at least not at first. Some patients do end up reducing their medication load after a successful TMS course because their symptoms improve enough to make that a reasonable option, but that happens gradually and with medical oversight. Going into TMS expecting to quit your antidepressants immediately afterward can set up unrealistic expectations and create unnecessary stress during a period when stability matters. The more practical framing is to treat TMS as an addition to your current care, one that works at a level your medication cannot reach on its own.
For the majority of patients taking SSRIs or SNRIs, there is no clinical reason to stop before beginning TMS. Medications like sertraline, escitalopram, fluoxetine, duloxetine, and venlafaxine have not been shown to interfere with TMS effectiveness or safety in any meaningful way, and abruptly stopping them carries real risks including withdrawal symptoms and a rebound in depressive symptoms. Stopping SSRIs before TMS is generally only considered when a specific medication poses a safety concern related to seizure threshold, not because of any general rule about combining the two approaches. Making that call without medical guidance can seriously undermine the stability a person needs to get through a 36-session treatment course.
The clinical literature on this point is fairly settled. A 2014 study published in the Journal of Clinical Psychiatry found no significant difference in TMS outcomes between patients who were on antidepressants during treatment and those who were not. What does matter more is whether the person has a responsive brain pattern, how many prior medication trials they have attempted, and whether they can maintain enough consistency to complete the full protocol. If you have been on an SSRI for years and it has only partially helped, that partial response does not disqualify you from TMS, and stepping off the medication before starting is unlikely to improve your results.
TMS does carry a small seizure risk, estimated at roughly 1 in 10,000 treatment sessions based on available data. That risk is low, but it becomes more relevant when someone is on a medication that already lowers the seizure threshold. Bupropion (Wellbutrin) is the most frequently discussed example in this category, particularly at higher doses, and tricyclic antidepressants like clomipramine and amitriptyline can also increase risk. Certain antipsychotics, stimulants at high doses, and some sleep medications similarly affect how the brain responds to electrical stimulation. This does not automatically mean those medications must be stopped, but it does mean the clinical team needs to review the full picture, including dosage, duration of use, and any personal or family history of seizures, before proceeding.
In some cases we can proceed with a modified protocol that uses lower stimulation intensities or a more gradual ramp-up schedule to reduce risk. In other cases, a conversation with the prescribing psychiatrist about whether a dose reduction makes sense ahead of TMS is the right step. These decisions are never made in a vacuum, because removing a medication someone depends on has its own risks, and those have to be weighed honestly against a seizure risk that remains quite small even with the medications mentioned above.
While some medications warrant caution, others appear to work in a complementary way with TMS. D-cycloserine, a partial NMDA receptor agonist sometimes used off-label in psychiatry, has been studied as a potential adjunct to TMS because it may enhance synaptic plasticity during stimulation. Some early research also suggests that certain serotonin-based medications could help consolidate the neurological changes TMS produces by keeping serotonin available at synapses during the period when the brain is actively reorganizing. None of this means any particular medication is guaranteed to boost your TMS results, but it does reinforce the point that the relationship between TMS and medication is more nuanced than a simple conflict. The goal of a thorough intake evaluation is to figure out which medications are helping, which are neutral, and which warrant a closer look, rather than applying a blanket rule in either direction.
Before anyone starts a TMS course here, we do a detailed review of every medication they are taking, including the dose, how long they have been on it, and why it was prescribed. That review is not just about flagging safety concerns; it is also about understanding what has and has not worked so we can build a treatment plan that makes sense for that specific person. I find that patients who come in with a clear record of their medication history, including which antidepressants they tried and how long each trial lasted, give us a much better starting point. If you are unsure what to bring, our questions to ask your TMS provider before treatment page can help you prepare for that first conversation.
We also coordinate with the patient’s existing prescribing psychiatrist or primary care provider whenever possible, because making medication changes without that collaboration creates gaps in care. TMS is an outpatient procedure and most people continue their normal routines throughout, which means their prescribing doctor remains an active part of the picture. What we want to avoid is a situation where a patient is getting conflicting guidance from multiple providers, or where they are making medication changes on their own because they assumed it was required. Clear communication across the care team prevents both of those problems, and it gives the patient a much more stable foundation for the weeks of treatment ahead.
If you continue your medication through TMS, your daily experience will be fairly straightforward. You take your medication as usual, come in for your TMS session (each one runs about 20 minutes), and then go about your day. There are no known pharmacokinetic interactions between standard antidepressants and the magnetic pulses used in TMS, meaning the treatment does not change how your body processes the medication or vice versa. Some people notice that their sensitivity to the medication’s effects shifts slightly as TMS begins to improve mood regulation, but this is generally a positive sign rather than a problem, and it is worth mentioning to your prescribing doctor so they can monitor whether any dose adjustments make sense down the line.
It is also worth knowing that improvement during TMS tends to be gradual. The signs TMS is working typically begin to appear around weeks two or three, and for many patients the full benefit continues to build for several weeks after the course ends. Staying on your antidepressant during this period provides a layer of stability that makes it easier to gauge what is changing and why. Patients who abruptly discontinue medication at the start of TMS sometimes find it difficult to separate the effects of the treatment from the effects of stopping the antidepressant, which can make the whole experience harder to interpret. Consistency on both fronts generally produces the clearest picture and the most stable outcome.
If you are weighing your options and want to understand how your current medications fit into a TMS plan, I encourage you to reach out to us directly. At Delray Brain Science, we review every patient’s full medication history before making any recommendations, and we work closely with your existing providers to make sure nothing falls through the cracks. Call our office or use the online contact form to schedule an evaluation and get a clear, honest picture of what treatment could look like for you.